Browse
Explore conditions, clinical trials, and the organisations running them.
Find a trial
Search by condition, then narrow by status and aim.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
130005 trials found · Page 6420 of 6501
-
Pfizer compares two pill versions in small Healthy-Volunteer study
Knowledge-focused CompletedStudy has two arms. Arm 1 has two cohorts in which each cohort, under the fasted state, will either be given a single oral dose of Form 1 in Period 1 followed by a single oral dose of Form 5 in Period 2 or a single oral dose of Form 5 in Period 1 followed by a single oral dose of…
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Bovine thymus extract put to the test in healthy volunteers
Knowledge-focused CompletedThe goal of this trial is to find out if Thymus Nuclear Extract is safe and well-tolerated in healthy men and women by testing three different dose levels and comparing the results to a placebo.
Sponsor: Standard Process Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New drug Y-3 tested in healthy people for first time in the U.S.
Knowledge-focused CompletedThe goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetic profiles of Y-3 in healthy adult volunteers in the United States. The main questions it aims to answer are: * What the pharmacokinetic profiles of single ascending doses of Y-3 (40 mg and …
Phase 1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Withdrawn study sought to unlock back pain mystery
Knowledge-focused CancelledThe purpose of this research study is to examine the effects of physical therapy on the spinal discs. Back pain is the number one cause of disability in the US, and the spine is the most common location of chronic pain in Veterans. Physical therapy is often very effective at impr…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New HIV pill for kids pulled before start
Disease control CancelledThe UNIVERSAL2 study is a research project designed to evaluate a newly developed formulation of an approved drug for children living with HIV aged over 3 years and weighing between 10 and 25 kg. The aim of UNIVERSAL2 is to determine the right dosage of this new formulation.
Phase 1/2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New eye test could replace painful scrape for infection diagnosis
Diagnosis CancelledMicrobial keratitis is a common and serious eye disease in Edinburgh. Prompt treatment with antibiotics can prevent sight loss, and identification of the micro-organism and its antibiotic sensitivities are key to appropriate management. Standard practice of collecting infected ma…
Sponsor: University of Edinburgh • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Study on teen body drawings withdrawn before starting
Knowledge-focused CancelledRepresentations of the inner body in adolescence: developmental characteristics and specificities in borderline personality disorders.
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Promising blood cancer combo trial pulled before it even started
Disease control CancelledThe goal of Part 1 of this clinical research study is to find the highest tolerable dose of ASTX029 that can be given in combination with ASTX727 to participants who have RAS-mutant MDS or MDS/MPN. The goal of Part 2 of this clinical research study is to learn if the dose of ASTX…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
First human test of new hepatitis d drug begins
Knowledge-focused CompletedThis study is designed to assess safety, tolerability, and pharmacokinetics of single ascending doses (SAD) and multiple-ascending doses (MAD) of ABI-6250 in healthy participants. Effect of food will also be evaluated in Part A.
Phase 1 • Sponsor: Assembly Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Migraine pill trial pulled before it began
Symptom relief Cancelled* This two-stage clinical trial will assess a novel combination therapy for acute migraine. In Stage 1 (factorial), participants will receive the combination, each individual component, or placebo. In Stage 2 (dose-finding), they will test three doses of the combination. Before b…
Phase 2 • Sponsor: Allodynic Therapeutics, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Lung cancer immunotherapy trial pulled before it began
Disease control CancelledThis study encompasses multicenter open-label, phase II trials. Patients will be dispatched into 2 cohorts: * Cohort A: Patients naïve from systemic treatment will be randomized according to two treatment modalities: atezolizumab + tiragolumab (arm A1) versus atezolizumab monot…
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Autoinjector or syringe? study tests how ADL-018 enters the body
Knowledge-focused CompletedThe Goal of these study is to assess the comparative pharmacokinetics of Test Product (A): ADL-018 Injection 150 mg/mL solution in a single dose pre-filled autoinjector, manufactured by Kashiv Biosciences LLC, USA with Reference Product (B): ADL-018 Injection 150mg/mL solution in…
Phase 1 • Sponsor: Kashiv BioSciences, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Blood cancer combo trial pulled before it even started
Disease control CancelledTo learn if olutasidenib, when combined with a drug called a hypomethylating agent (HMA) can help to control MDS, CMML, and/or MPN. The safety of the drug combination will also be studied.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
COVID-19 'Treatment' study pulled before a single volunteer signed up
Knowledge-focused CancelledSARS-CoV-2 produced strong pluripotent stem cells and brain cells to protect Telomere chromosomes to maintain Acid Deoxyribonucleic (ADN) Molecules.
Phase 2 • Sponsor: DHA Coffee Co., Ltd • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:46 UTC
-
New tool measures Seniors' computer Know-How in turkey
Knowledge-focused CompletedThe Computer Proficiency Questionnaire (CPQ) assesses older individuals' computer and information technology skills. The questionnaire promotes digital inclusion by tailoring training packages to meet individual requirements. The CPQ serves as a continuous evaluation tool to trac…
Sponsor: Uludag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Pain relief study for hernia patients pulled before start
Symptom relief CancelledThe study is designed to evaluate the safety, efficacy, and pharmacokinetics (PK) of three ascending doses of AMT-143 to determine the appropriate dose of AMT-143 for the management of postsurgical pain following inguinal hernia repair.
Phase 2 • Sponsor: AmacaThera Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New bandage stays put in Head-to-Head test
Knowledge-focused CompletedThe purpose of this study is to evaluate a new prototype multilayer foam dressing on healthy, intact skin. The study will find out how well the new prototype dressing stays in place as well as other dressing performance and safety factors when compared to two corresponding, mark…
Sponsor: Smith & Nephew, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
BPH treatment comparison study pulled before it started
Knowledge-focused CancelledThe objective of the RELIEF Study is to compare the safety, effectiveness and patient experience outcomes in real-world subjects treated with different modalities for symptomatic BPH.
Sponsor: NeoTract, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
CO poisoning treatment study cut short after only two patients
Knowledge-focused Stopped earlyThe optimal treatment strategy with hyperbaric oxygen therapy has been the subject of some debate over the past 3 decades. Initial landmark studies showed a decrease in the incidence of DNS with a single treatment and also with three treatments over the course of 24 hours. These …
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Healthy men needed to test safety of experimental drug
Knowledge-focused Recruiting nowThe trial aims to study the safety, tolerability, and pharmacokinetics of single and multiple rising doses of BI 3776528.
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC